Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Zhejiang Jingxin Pharmaceutical Co., Ltd.
FDA Inspection
•Zhejiang Jingxin Pharmaceutical Co., Ltd.•October 17, 2025

FDA Inspection 1290202 - Zhejiang Jingxin Pharmaceutical Co., Ltd. - October 17, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Zhejiang Jingxin Pharmaceutical Co., Ltd., with an inspection on October 17, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Inspection Date
October 17, 2025
Product Type
Human Drugs
Office
Office of Inspections and Investigations
Open in Dashboard

ID · 57dddb9e-134f-4ff1-8630-0b0f65b6729e

Violation Codes2
21 CFR 211.165(b)21 CFR 211.84(d)(1)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.